FdaApplication
NDA 214835
Identifiers
- fda_app_no: NDA214835
Properties
| Property | Value |
|---|---|
| applicant_name | LABORATORIOS FARMACEUTICOS ROVI SA |
| application_type | NDA |
| approval_date | 2024-03-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISVAN | RISPERIDONE | 75MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| RISVAN | RISPERIDONE | 100MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
2 products